世界の自家幹細胞＆非幹細胞系治療法市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3876 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、自家幹細胞＆非幹細胞系治療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（自家幹細胞治療、非幹細胞治療）、用途別市場規模（がん、神経変性疾患、循環器疾患、自己免疫疾患、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・自家幹細胞＆非幹細胞系治療法の市場動向 ・企業の競争状況、市場シェア ・自家幹細胞＆非幹細胞系治療法の種類別市場規模と予測2016-2027（自家幹細胞治療、非幹細胞治療） ・自家幹細胞＆非幹細胞系治療法の用途別市場規模と予測2016-2027（がん、神経変性疾患、循環器疾患、自己免疫疾患、その他） ・自家幹細胞＆非幹細胞系治療法の北米市場規模2016-2027（アメリカ、カナダ） ・自家幹細胞＆非幹細胞系治療法の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・自家幹細胞＆非幹細胞系治療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・自家幹細胞＆非幹細胞系治療法の中南米市場規模2016-2027（メキシコ、ブラジル） ・自家幹細胞＆非幹細胞系治療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Fibrocell Science, Inc.、Vericel Corporation、Dendreon Corporation (Sanpower Group)、Caladrius Biosciences, Inc.、BrainStorm Cell Therapeutics、Regeneus Ltd.、Genzyme Corporation、Pluristem Therapeutics Inc、U.S. Stem Cell, Inc、TiGenix (Takeda)） ・結論

Market Analysis and Insights: Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market
The global Autologous Stem Cell and Non-Stem Cell Based Therapies market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Autologous Stem Cell and Non-Stem Cell Based Therapies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Autologous Stem Cell and Non-Stem Cell Based Therapies market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Autologous Stem Cell and Non-Stem Cell Based Therapies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Autologous Stem Cell and Non-Stem Cell Based Therapies market.

Global Autologous Stem Cell and Non-Stem Cell Based Therapies Scope and Market Size
Autologous Stem Cell and Non-Stem Cell Based Therapies market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Autologous Stem Cell and Non-Stem Cell Based Therapies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Autologous Stem Cell Therapy
Non-Stem Cell Therapy

Segment by Application
Cancer
Neurodegenerative Disorders
Cardiovascular Disease
Autoimmune Diseases
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Fibrocell Science, Inc.
Vericel Corporation
Dendreon Corporation (Sanpower Group)
Caladrius Biosciences, Inc.
BrainStorm Cell Therapeutics
Regeneus Ltd.
Genzyme Corporation
Pluristem Therapeutics Inc
U.S. Stem Cell, Inc
TiGenix (Takeda)

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Autologous Stem Cell Therapy
1.2.3 Non-Stem Cell Therapy
1.3 Market by Application
1.3.1 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cancer
1.3.3 Neurodegenerative Disorders
1.3.4 Cardiovascular Disease
1.3.5 Autoimmune Diseases
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Perspective (2016-2027)
2.2 Autologous Stem Cell and Non-Stem Cell Based Therapies Growth Trends by Regions
2.2.1 Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Autologous Stem Cell and Non-Stem Cell Based Therapies Historic Market Share by Regions (2016-2021)
2.2.3 Autologous Stem Cell and Non-Stem Cell Based Therapies Forecasted Market Size by Regions (2022-2027)
2.3 Autologous Stem Cell and Non-Stem Cell Based Therapies Industry Dynamic
2.3.1 Autologous Stem Cell and Non-Stem Cell Based Therapies Market Trends
2.3.2 Autologous Stem Cell and Non-Stem Cell Based Therapies Market Drivers
2.3.3 Autologous Stem Cell and Non-Stem Cell Based Therapies Market Challenges
2.3.4 Autologous Stem Cell and Non-Stem Cell Based Therapies Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Autologous Stem Cell and Non-Stem Cell Based Therapies Players by Revenue
3.1.1 Global Top Autologous Stem Cell and Non-Stem Cell Based Therapies Players by Revenue (2016-2021)
3.1.2 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Market Share by Players (2016-2021)
3.2 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue
3.4 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Concentration Ratio
3.4.1 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue in 2020
3.5 Autologous Stem Cell and Non-Stem Cell Based Therapies Key Players Head office and Area Served
3.6 Key Players Autologous Stem Cell and Non-Stem Cell Based Therapies Product Solution and Service
3.7 Date of Enter into Autologous Stem Cell and Non-Stem Cell Based Therapies Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Autologous Stem Cell and Non-Stem Cell Based Therapies Breakdown Data by Type
4.1 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Historic Market Size by Type (2016-2021)
4.2 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Forecasted Market Size by Type (2022-2027)

5 Autologous Stem Cell and Non-Stem Cell Based Therapies Breakdown Data by Application
5.1 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Historic Market Size by Application (2016-2021)
5.2 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size (2016-2027)
6.2 North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type
6.2.1 North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2016-2021)
6.2.2 North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2022-2027)
6.2.3 North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2016-2027)
6.3 North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application
6.3.1 North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2016-2021)
6.3.2 North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2022-2027)
6.3.3 North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2016-2027)
6.4 North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country
6.4.1 North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2016-2021)
6.4.2 North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size (2016-2027)
7.2 Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type
7.2.1 Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2016-2021)
7.2.2 Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2022-2027)
7.2.3 Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2016-2027)
7.3 Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application
7.3.1 Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2016-2021)
7.3.2 Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2022-2027)
7.3.3 Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2016-2027)
7.4 Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country
7.4.1 Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2016-2021)
7.4.2 Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size (2016-2027)
8.2 Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type
8.2.1 Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2016-2027)
8.3 Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application
8.3.1 Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2016-2027)
8.4 Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Region
8.4.1 Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size (2016-2027)
9.2 Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type
9.2.1 Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2016-2021)
9.2.2 Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2022-2027)
9.2.3 Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2016-2027)
9.3 Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application
9.3.1 Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2016-2021)
9.3.2 Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2022-2027)
9.3.3 Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2016-2027)
9.4 Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country
9.4.1 Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2016-2021)
9.4.2 Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size (2016-2027)
10.2 Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type
10.2.1 Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2016-2027)
10.3 Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application
10.3.1 Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2016-2027)
10.4 Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country
10.4.1 Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Fibrocell Science, Inc.
11.1.1 Fibrocell Science, Inc. Company Details
11.1.2 Fibrocell Science, Inc. Business Overview
11.1.3 Fibrocell Science, Inc. Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction
11.1.4 Fibrocell Science, Inc. Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021)
11.1.5 Fibrocell Science, Inc. Recent Development
11.2 Vericel Corporation
11.2.1 Vericel Corporation Company Details
11.2.2 Vericel Corporation Business Overview
11.2.3 Vericel Corporation Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction
11.2.4 Vericel Corporation Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021)
11.2.5 Vericel Corporation Recent Development
11.3 Dendreon Corporation (Sanpower Group)
11.3.1 Dendreon Corporation (Sanpower Group) Company Details
11.3.2 Dendreon Corporation (Sanpower Group) Business Overview
11.3.3 Dendreon Corporation (Sanpower Group) Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction
11.3.4 Dendreon Corporation (Sanpower Group) Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021)
11.3.5 Dendreon Corporation (Sanpower Group) Recent Development
11.4 Caladrius Biosciences, Inc.
11.4.1 Caladrius Biosciences, Inc. Company Details
11.4.2 Caladrius Biosciences, Inc. Business Overview
11.4.3 Caladrius Biosciences, Inc. Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction
11.4.4 Caladrius Biosciences, Inc. Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021)
11.4.5 Caladrius Biosciences, Inc. Recent Development
11.5 BrainStorm Cell Therapeutics
11.5.1 BrainStorm Cell Therapeutics Company Details
11.5.2 BrainStorm Cell Therapeutics Business Overview
11.5.3 BrainStorm Cell Therapeutics Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction
11.5.4 BrainStorm Cell Therapeutics Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021)
11.5.5 BrainStorm Cell Therapeutics Recent Development
11.6 Regeneus Ltd.
11.6.1 Regeneus Ltd. Company Details
11.6.2 Regeneus Ltd. Business Overview
11.6.3 Regeneus Ltd. Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction
11.6.4 Regeneus Ltd. Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021)
11.6.5 Regeneus Ltd. Recent Development
11.7 Genzyme Corporation
11.7.1 Genzyme Corporation Company Details
11.7.2 Genzyme Corporation Business Overview
11.7.3 Genzyme Corporation Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction
11.7.4 Genzyme Corporation Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021)
11.7.5 Genzyme Corporation Recent Development
11.8 Pluristem Therapeutics Inc
11.8.1 Pluristem Therapeutics Inc Company Details
11.8.2 Pluristem Therapeutics Inc Business Overview
11.8.3 Pluristem Therapeutics Inc Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction
11.8.4 Pluristem Therapeutics Inc Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021)
11.8.5 Pluristem Therapeutics Inc Recent Development
11.9 U.S. Stem Cell, Inc
11.9.1 U.S. Stem Cell, Inc Company Details
11.9.2 U.S. Stem Cell, Inc Business Overview
11.9.3 U.S. Stem Cell, Inc Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction
11.9.4 U.S. Stem Cell, Inc Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021)
11.9.5 U.S. Stem Cell, Inc Recent Development
11.10 TiGenix (Takeda)
11.10.1 TiGenix (Takeda) Company Details
11.10.2 TiGenix (Takeda) Business Overview
11.10.3 TiGenix (Takeda) Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction
11.10.4 TiGenix (Takeda) Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021)
11.10.5 TiGenix (Takeda) Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Autologous Stem Cell Therapy
Table 3. Key Players of Non-Stem Cell Therapy
Table 4. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Regions (2016-2021)
Table 8. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Regions (2022-2027)
Table 10. Autologous Stem Cell and Non-Stem Cell Based Therapies Market Trends
Table 11. Autologous Stem Cell and Non-Stem Cell Based Therapies Market Drivers
Table 12. Autologous Stem Cell and Non-Stem Cell Based Therapies Market Challenges
Table 13. Autologous Stem Cell and Non-Stem Cell Based Therapies Market Restraints
Table 14. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Players (2016-2021)
Table 16. Global Top Autologous Stem Cell and Non-Stem Cell Based Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies as of 2020)
Table 17. Ranking of Global Top Autologous Stem Cell and Non-Stem Cell Based Therapies Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Autologous Stem Cell and Non-Stem Cell Based Therapies Product Solution and Service
Table 21. Date of Enter into Autologous Stem Cell and Non-Stem Cell Based Therapies Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Market Share by Type (2016-2021)
Table 25. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Market Share by Application (2016-2021)
Table 29. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2022-2027) & (US$ Million)
Table 61. Fibrocell Science, Inc. Company Details
Table 62. Fibrocell Science, Inc. Business Overview
Table 63. Fibrocell Science, Inc. Autologous Stem Cell and Non-Stem Cell Based Therapies Product
Table 64. Fibrocell Science, Inc. Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021) & (US$ Million)
Table 65. Fibrocell Science, Inc. Recent Development
Table 66. Vericel Corporation Company Details
Table 67. Vericel Corporation Business Overview
Table 68. Vericel Corporation Autologous Stem Cell and Non-Stem Cell Based Therapies Product
Table 69. Vericel Corporation Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021) & (US$ Million)
Table 70. Vericel Corporation Recent Development
Table 71. Dendreon Corporation (Sanpower Group) Company Details
Table 72. Dendreon Corporation (Sanpower Group) Business Overview
Table 73. Dendreon Corporation (Sanpower Group) Autologous Stem Cell and Non-Stem Cell Based Therapies Product
Table 74. Dendreon Corporation (Sanpower Group) Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021) & (US$ Million)
Table 75. Dendreon Corporation (Sanpower Group) Recent Development
Table 76. Caladrius Biosciences, Inc. Company Details
Table 77. Caladrius Biosciences, Inc. Business Overview
Table 78. Caladrius Biosciences, Inc. Autologous Stem Cell and Non-Stem Cell Based Therapies Product
Table 79. Caladrius Biosciences, Inc. Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021) & (US$ Million)
Table 80. Caladrius Biosciences, Inc. Recent Development
Table 81. BrainStorm Cell Therapeutics Company Details
Table 82. BrainStorm Cell Therapeutics Business Overview
Table 83. BrainStorm Cell Therapeutics Autologous Stem Cell and Non-Stem Cell Based Therapies Product
Table 84. BrainStorm Cell Therapeutics Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021) & (US$ Million)
Table 85. BrainStorm Cell Therapeutics Recent Development
Table 86. Regeneus Ltd. Company Details
Table 87. Regeneus Ltd. Business Overview
Table 88. Regeneus Ltd. Autologous Stem Cell and Non-Stem Cell Based Therapies Product
Table 89. Regeneus Ltd. Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021) & (US$ Million)
Table 90. Regeneus Ltd. Recent Development
Table 91. Genzyme Corporation Company Details
Table 92. Genzyme Corporation Business Overview
Table 93. Genzyme Corporation Autologous Stem Cell and Non-Stem Cell Based Therapies Product
Table 94. Genzyme Corporation Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021) & (US$ Million)
Table 95. Genzyme Corporation Recent Development
Table 96. Pluristem Therapeutics Inc Company Details
Table 97. Pluristem Therapeutics Inc Business Overview
Table 98. Pluristem Therapeutics Inc Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021) & (US$ Million)
Table 99. Pluristem Therapeutics Inc Recent Development
Table 100. U.S. Stem Cell, Inc Company Details
Table 101. U.S. Stem Cell, Inc Business Overview
Table 102. U.S. Stem Cell, Inc Autologous Stem Cell and Non-Stem Cell Based Therapies Product
Table 103. U.S. Stem Cell, Inc Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021) & (US$ Million)
Table 104. U.S. Stem Cell, Inc Recent Development
Table 105. TiGenix (Takeda) Company Details
Table 106. TiGenix (Takeda) Business Overview
Table 107. TiGenix (Takeda) Autologous Stem Cell and Non-Stem Cell Based Therapies Product
Table 108. TiGenix (Takeda) Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021) & (US$ Million)
Table 109. TiGenix (Takeda) Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Type: 2020 VS 2027
Figure 2. Autologous Stem Cell Therapy Features
Figure 3. Non-Stem Cell Therapy Features
Figure 4. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Application: 2020 VS 2027
Figure 5. Cancer Case Studies
Figure 6. Neurodegenerative Disorders Case Studies
Figure 7. Cardiovascular Disease Case Studies
Figure 8. Autoimmune Diseases Case Studies
Figure 9. Others Case Studies
Figure 10. Autologous Stem Cell and Non-Stem Cell Based Therapies Report Years Considered
Figure 11. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Regions: 2020 VS 2027
Figure 14. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Regions (2022-2027)
Figure 15. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Players in 2020
Figure 16. Global Top Autologous Stem Cell and Non-Stem Cell Based Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue in 2020
Figure 18. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Market Share by Type (2016-2021)
Figure 19. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Market Share by Type (2022-2027)
Figure 20. North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Type (2016-2027)
Figure 22. North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Application (2016-2027)
Figure 23. North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Country (2016-2027)
Figure 24. United States Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Type (2016-2027)
Figure 28. Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Application (2016-2027)
Figure 29. Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Country (2016-2027)
Figure 30. Germany Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Region (2016-2027)
Figure 40. China Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Type (2016-2027)
Figure 48. Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Application (2016-2027)
Figure 49. Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Country (2016-2027)
Figure 50. Mexico Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Country (2016-2027)
Figure 56. Turkey Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Fibrocell Science, Inc. Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021)
Figure 60. Vericel Corporation Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021)
Figure 61. Dendreon Corporation (Sanpower Group) Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021)
Figure 62. Caladrius Biosciences, Inc. Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021)
Figure 63. BrainStorm Cell Therapeutics Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021)
Figure 64. Regeneus Ltd. Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021)
Figure 65. Genzyme Corporation Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021)
Figure 66. Pluristem Therapeutics Inc Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021)
Figure 67. U.S. Stem Cell, Inc Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021)
Figure 68. TiGenix (Takeda) Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---